(Alliance News) - Stock prices in London opened higher in London on Thursday, as optimism returned to the markets and fears of banking crisis contagion faded. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, March 20, after completing its quarterly review. Read More
(Alliance News) - No mid-cap stock will break into London's FTSE 100 blue-chip benchmark at the next index review, according to indicative changes provided by FTSE Russell on Tuesday. Read More
(Alliance News) - UK retailers will only enjoy a "meaningful" recovery in 2024, with consumer discretionary income to remain under pressure next year too, analysts at Stifel predicted. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and last week and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London made little progress on Thursday morning, amid fears for the global economy and despite a slew of local corporate updates. Read More
(Alliance News) - Moonpig Group PLC on Wednesday joined other struggling online retailers as it saw interim profit slashed in half amid "dampened investor appetite" and "squeezed household budgets". Read More
(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More
(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks. Read More
(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains for pharmaceuticals as GSK shook off Zantac litigation. Read More